GB0206655D0 - Novel process - Google Patents
Novel processInfo
- Publication number
- GB0206655D0 GB0206655D0 GBGB0206655.3A GB0206655A GB0206655D0 GB 0206655 D0 GB0206655 D0 GB 0206655D0 GB 0206655 A GB0206655 A GB 0206655A GB 0206655 D0 GB0206655 D0 GB 0206655D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel process
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0206655.3A GB0206655D0 (en) | 2002-03-21 | 2002-03-21 | Novel process |
| AU2003212376A AU2003212376A1 (en) | 2002-03-21 | 2003-03-19 | Process for the preparation of intermediates in the synthesis of 2- (purin-9-yl) - tetrahydrofuran-3,4-diol derivatives |
| PCT/EP2003/003027 WO2003080613A1 (en) | 2002-03-21 | 2003-03-19 | Process for the preparation of intermediates in the synthesis of 2- (purin-9-yl) - tetrahydrofuran-3,4-diol derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0206655.3A GB0206655D0 (en) | 2002-03-21 | 2002-03-21 | Novel process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0206655D0 true GB0206655D0 (en) | 2002-05-01 |
Family
ID=9933422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0206655.3A Ceased GB0206655D0 (en) | 2002-03-21 | 2002-03-21 | Novel process |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003212376A1 (en) |
| GB (1) | GB0206655D0 (en) |
| WO (1) | WO2003080613A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20060272A1 (en) | 2004-05-24 | 2006-05-22 | Glaxo Group Ltd | (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST |
| GB0514809D0 (en) * | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU44900A (en) * | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| CN1313861A (en) * | 1998-06-23 | 2001-09-19 | 葛兰素集团有限公司 | 2-(purin-9-YL)-tetrahydrofuran-3,4-diolderivatives |
-
2002
- 2002-03-21 GB GBGB0206655.3A patent/GB0206655D0/en not_active Ceased
-
2003
- 2003-03-19 AU AU2003212376A patent/AU2003212376A1/en not_active Abandoned
- 2003-03-19 WO PCT/EP2003/003027 patent/WO2003080613A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003080613A1 (en) | 2003-10-02 |
| AU2003212376A1 (en) | 2003-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0210143D0 (en) | Process | |
| GB0211789D0 (en) | Process | |
| GB0225701D0 (en) | Process | |
| GB0213485D0 (en) | Process | |
| GB0205016D0 (en) | Process | |
| GB0201505D0 (en) | Process | |
| GB0210225D0 (en) | Process | |
| GB0205014D0 (en) | Process | |
| PL372214A1 (en) | Novel process | |
| GB0201378D0 (en) | Process | |
| GB0212974D0 (en) | Process | |
| GB0202563D0 (en) | Process | |
| GB0218014D0 (en) | Process | |
| GB0219292D0 (en) | Process | |
| GB0228950D0 (en) | Process | |
| GB0210183D0 (en) | Process | |
| GB0229476D0 (en) | Novel process | |
| GB0206655D0 (en) | Novel process | |
| GB0203665D0 (en) | Process | |
| GB0210185D0 (en) | Process | |
| GB0219829D0 (en) | Process | |
| GB0228894D0 (en) | Process | |
| GB0213769D0 (en) | Novel process | |
| GB0204717D0 (en) | Novel process | |
| GB0221226D0 (en) | Novel process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |